Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Debt / NOTE 1.250% 9/1
-
Market price (% of par)
-
116.98%
-
Total 13F principal
-
$1,025,219,311
-
Principal change
-
-$10,127,712
-
Total reported market value
-
$1,240,011,569
-
Number of holders
-
62
-
Value change
-
-$17,028,924,411
-
Number of buys
-
22
-
Number of sells
-
33
Institutional Holders of SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 as of Q1 2024
As of 31 Mar 2024,
SAREPTA THERAPEUTICS INC - NOTE 1.250% 9/1 was held by
62 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$1,025,219,311
in principal (par value) of the bond.
The largest 10 bondholders included
Linden Advisors LP, WOLVERINE ASSET MANAGEMENT LLC, ADVENT CAPITAL MANAGEMENT /DE/, Calamos Advisors LLC, BlackRock Inc., BRAIDWELL LP, LAZARD ASSET MANAGEMENT LLC, Davidson Kempner Capital Management LP, READYSTATE ASSET MANAGEMENT LP, and CITADEL ADVISORS LLC.
This page lists
63
institutional bondholders reporting positions
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.